In this file
The $99 visit is separate from the prescription cost. That detail matters when comparing the proposed prescription, payment schedule, and access to help.
This provider file follows the company’s published material and the questions it leaves open. It covers the care arrangement, price, cancellation boundaries, and contact routes; it does not certify the business or determine whether a treatment is appropriate for a particular person.
Understand the care arrangement
QuickMD’s weight-loss page offers a visit-based route to medical assessment. A clinician reviews the patient and may send an appropriate prescription to a pharmacy of the patient’s choice. The model is useful to understand as a consultation service, rather than assuming that the quoted visit includes a shipped month of treatment.
Name the organizations involved in your own plan. The website operator, clinical practice, and pharmacy may be separate businesses. A patient should know which one is responsible for a medical decision, which holds the account, and which handles the medication.
Read the price in its proper context
The reviewed page prices a weight-loss visit at $99 and says medication is paid separately. No membership is required for this pathway. A fair comparison adds the actual pharmacy price and the number of follow-up appointments needed over the same period as a subscription offer.
Record the total paid today, the period it buys, and the next payment. If a figure is expressed per month but collected for several months, keep both numbers in the comparison. Our price-comparison worksheet helps separate a low initial figure from the continuing commitment.
Find the cancellation boundary
Before booking, check the appointment-cancellation and refund terms that apply to the specific visit. A completed evaluation can remain a paid professional service even when the requested medicine is not prescribed. Pharmacy cancellation rules apply separately after a prescription is sent or filled.
A useful request names the next renewal and the current order separately. Ask for confirmation of both the effective cancellation date and the pharmacy status. Instructions for stopping or changing the medicine itself need to come from the treating professional.
Identify the actual prescription
QuickMD lists familiar GLP-1 medicines as possible treatment options, subject to clinical assessment. That is not a promise that each medicine is appropriate or stocked by a selected pharmacy. Establish the product, pharmacy, coverage, and continuing care arrangement before making a transfer.
FDA approval concerns a particular drug product. A compounded preparation has not received that approval, and evidence for a different formulation cannot guarantee an individual result. Read the product-approval explanation and ask questions about the exact medicine proposed.
Contact and account help
A general patient telephone number or email was not established from the documents selected for this file. We leave that gap visible rather than reconstructing a masked address or publishing an unrelated department’s number.
A general patient phone and email were not established from the selected documents. Start with the official website and its patient-support navigation.
Start from the official QuickMD website to find its verified patient-account navigation. We have not signed into a private portal or measured its support response. Do not share passwords, access codes, payment-card details, or medical records with a review site.
Bring one concrete question to the consultation
Does my $99 payment cover this visit only, and what follow-up will be needed if the clinician starts or continues treatment?
Write the answer beside the proposed prescription and agreement. If it describes a different product, an expired promotion, or a plan you are not eligible for, ask for clarification. Our pre-purchase checklist can help keep those questions organized.
Compare a different arrangement
The QuickMD alternatives guide compares care and payment structures relevant to this file. CoreAge Rx’s first place in that list is a disclosed commercial placement, not an independent clinical ranking.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- FAQs For Our Telehealth and Online Medical Services | QuickMD ↗Provider-published information · Checked September 22, 2026
- Terms of Service | QuickMD ↗Provider-published information · Checked September 22, 2026
- Online Medical Weight Loss Medications | QuickMD ↗Provider-published information · Checked September 22, 2026
- Online Doctor Visits, Same-Day Appointments | QuickMD ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026